Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
NOT YET RECRUITING
NCT05623501
PHASE1
Phase I, Dose-Escalation Study of Dihydromyricetin (DHM) to Treat Alcohol-Associated Liver Disease
Sponsor: University of Southern California
View on ClinicalTrials.gov
Summary
The current proposal is designed as a first-in-human Phase 1 open-label, dose-escalation study to assess the safety, pharmacokinetics, and the maximum tolerated dose of DHM among healthy volunteers using a purified form of DHM from a local cGMP compliant source (Master Herbs, Inc).
Key Details
Gender
All
Age Range
18 Years - 60 Years
Study Type
INTERVENTIONAL
Enrollment
12
Start Date
2024-09-15
Completion Date
2025-12-31
Last Updated
2024-09-03
Healthy Volunteers
Yes
Conditions
Interventions
DRUG
Dihydromyricetin
Dose-escalation and lysine preparation
Locations (1)
University of Southern California
Los Angeles, California, United States